BridgeBio Pharma, Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (7 lists). Names and jurisdictions are as filed.
- 2026-02-24: Subsidiary Entity name; Jurisdiction Ownership % as of December 31, 2025.
- 2026-02-24: Subsidiary BB Square Capital Investors I, LP; Jurisdiction Delaware.
- 2026-02-24: Subsidiary BB Square Capital, LLC; Jurisdiction Delaware.
- 2026-02-24: Subsidiary BB Square Holdings, LLC; Jurisdiction Delaware.
| Annual report filed | Subsidiary | Jurisdiction |
|---|
| 2026-02-24 | Entity name | Ownership % as of December 31, 2025 |
|---|
| 2026-02-24 | BB Square Capital Investors I, LP | Delaware |
|---|
| 2026-02-24 | BB Square Capital, LLC | Delaware |
|---|
| 2026-02-24 | BB Square Holdings, LLC | Delaware |
|---|
| 2026-02-24 | BB Square Investors GP I, LLC | Delaware |
|---|
| 2026-02-24 | BB Square LP Investment, LLC | Delaware |
|---|
| 2026-02-24 | BridgeBio Chemistry, Inc. | Delaware |
|---|
| 2026-02-24 | BridgeBio Gene Therapy LLC | Delaware |
|---|
| 2026-02-24 | BridgeBio Gene Therapy Research, Inc. | Delaware |
|---|
| 2026-02-24 | BridgeBio Pharma LLC | Delaware |
|---|
| 2026-02-24 | BridgeBio Services Inc. | Delaware |
|---|
| 2026-02-24 | Calcilytix Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Cyan Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | DTD Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Eidos Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | CoA Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Origin Biosciences, Inc. | Delaware |
|---|
| 2026-02-24 | Adrenas Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | QED Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Sub22, Inc. | Delaware |
|---|
| 2026-02-24 | Ferro Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Eulamin Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Cantero Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Venthera, Inc. | Delaware |
|---|
| 2026-02-24 | G Protein Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Molecular Skin Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Phoenix Tissue Repair, Inc. | Delaware |
|---|
| 2026-02-24 | Navire Pharma, Inc. | Delaware |
|---|
| 2026-02-24 | ML Bio Solutions, Inc. | Delaware |
|---|
| 2026-02-24 | Sen Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | Audition Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | BridgeBio Pharma Canada, ULC | Canada |
|---|
| 2026-02-24 | BridgeBio Pharma Cayman | Cayman Islands |
|---|
| 2026-02-24 | BridgeBio France SAS | France |
|---|
| 2026-02-24 | BridgeBio Germany GmbH | Germany |
|---|
| 2026-02-24 | BridgeBio Pharma (HK) Limited | Hong Kong |
|---|
| 2026-02-24 | BridgeBio Europe B.V. | Netherlands |
|---|
| 2026-02-24 | BridgeBio International GmbH | Switzerland |
|---|
| 2026-02-24 | BridgeBio UK Limited | United Kingdom |
|---|
| 2026-02-24 | Evanesco Therapeutics, Inc. | Delaware |
|---|
| 2026-02-24 | BridgeBio Pharma Europe B.V. | Netherlands |
|---|